ERBB2 and cancer: However, the VLDL reduction resulted only partially, not reaching the level observed in the CTR indicating that the abnormal lipids mobilization induced by the HER2-positive BC may require much more time for its normalization, thus, indicating that cancer may strongly modify the host metabolism far away from its homeostasis status.